$5.99
00.00%
Pre-Market: 6:29 AM EDT
15 minutes delayed
Comments
Loading...
WAVE Life Sciences
WVENASDAQ
want to know what
the Bulls & Bears Say?
WAVE Life Sciences (NASDAQ:WVE) Stock, Analyst Ratings, Price Targets, Forecasts
WAVE Life Sciences Ltd has a consensus price target of $11.63 based on the ratings of 8 analysts. The high is $19 issued by Mizuho on June 25, 2024. The low is $5 issued by RBC Capital on March 7, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Mizuho, and Wells Fargo on June 26, 2024, June 25, 2024, and May 15, 2024, respectively. With an average price target of $15 between HC Wainwright & Co., Mizuho, and Wells Fargo, there's an implied 150.42% upside for WAVE Life Sciences Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Mizuho
Wells Fargo
Truist Securities
RBC Capital
1calculated from analyst ratings
Analyst Ratings for WAVE Life Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/26/2024 | Buy Now | 150.42% | HC Wainwright & Co. | Andrew Fein | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/25/2024 | Buy Now | 217.2% | Mizuho | Salim Syed | $19 → $19 | Reiterates | Outperform → Outperform | Get Alert |
| 05/15/2024 | Buy Now | 83.64% | Wells Fargo | Tiago Fauth | → $11 | Initiates | → Overweight | Get Alert |
| 04/01/2024 | Buy Now | 183.81% | Truist Securities | Joon Lee | $17 → $17 | Reiterates | Buy → Buy | Get Alert |
| 03/12/2024 | Buy Now | 217.2% | Mizuho | Salim Syed | $10 → $19 | Maintains | Buy | Get Alert |
| 03/07/2024 | Buy Now | -16.53% | RBC Capital | Luca Issi | → $5 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 03/07/2024 | Buy Now | 150.42% | HC Wainwright & Co. | Andrew Fein | $8 → $15 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | 100.33% | Leerink Partners | Mani Foroohar | → $12 | Upgrade | Market Perform → Outperform | Get Alert |
| 08/04/2023 | Buy Now | 33.56% | HC Wainwright & Co. | Andrew Fein | → $8 | Reiterates | Buy → Buy | Get Alert |
| 07/05/2023 | Buy Now | 16.86% | Raymond James | Steven Seedhouse | → $7 | Initiates | → Outperform | Get Alert |
| 06/23/2023 | Buy Now | 183.81% | Truist Securities | Joon Lee | → $17 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2023 | Buy Now | 66.94% | Mizuho | Salim Syed | $13 → $10 | Maintains | Buy | Get Alert |
| 05/24/2023 | Buy Now | 33.56% | HC Wainwright & Co. | Andrew Fein | → $8 | Reiterates | Buy → Buy | Get Alert |
| 05/04/2023 | Buy Now | -16.53% | RBC Capital | Luca Issi | → $5 | Reiterates | → Sector Perform | Get Alert |
| 04/14/2023 | Buy Now | 117.03% | Mizuho | Salim Syed | → $13 | Reiterates | → Buy | Get Alert |
| 03/23/2023 | Buy Now | 33.56% | HC Wainwright & Co. | Andrew Fein | → $8 | Reiterates | → Buy | Get Alert |
| 12/14/2022 | Buy Now | 16.86% | SVB Leerink | Mani Foroohar | $2 → $7 | Maintains | Market Perform | Get Alert |
| 11/11/2022 | Buy Now | -16.53% | RBC Capital | Luca Issi | $8 → $5 | Maintains | Sector Perform | Get Alert |
| 05/13/2022 | Buy Now | 33.56% | HC Wainwright & Co. | Andrew Fein | $10 → $8 | Maintains | Buy | Get Alert |
| 05/13/2022 | Buy Now | -49.92% | SVB Leerink | Mani Foroohar | $7 → $3 | Maintains | Market Perform | Get Alert |
FAQ
What is the target price for WAVE Life Sciences (WVE) stock?
The latest price target for WAVE Life Sciences (NASDAQ:WVE) was reported by HC Wainwright & Co. on June 26, 2024. The analyst firm set a price target for $15.00 expecting WVE to rise to within 12 months (a possible 150.42% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for WAVE Life Sciences (WVE)?
The latest analyst rating for WAVE Life Sciences (NASDAQ:WVE) was provided by HC Wainwright & Co., and WAVE Life Sciences reiterated their buy rating.
When was the last upgrade for WAVE Life Sciences (WVE)?
The last upgrade for WAVE Life Sciences Ltd happened on December 19, 2023 when Leerink Partners raised their price target to $12. Leerink Partners previously had a market perform for WAVE Life Sciences Ltd.
When was the last downgrade for WAVE Life Sciences (WVE)?
There is no last downgrade for WAVE Life Sciences.
When is the next analyst rating going to be posted or updated for WAVE Life Sciences (WVE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of WAVE Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for WAVE Life Sciences was filed on June 26, 2024 so you should expect the next rating to be made available sometime around June 26, 2025.
Is the Analyst Rating WAVE Life Sciences (WVE) correct?
While ratings are subjective and will change, the latest WAVE Life Sciences (WVE) rating was a reiterated with a price target of $15.00 to $15.00. The current price WAVE Life Sciences (WVE) is trading at is $5.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.